Ligand Pharmaceuticals reported $11.45M in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acorda Therapeutics ACOR:US $ 13.3M 1.98M
Agenus AGEN:US $ 817K 150K
Amgen AMGN:US $ 1609M 28M
Anika Therapeutics ANIK:US $ 16.51M 0.82M
Baxter International BAX:US $ 1883M 27M
Bristol Myers Squibb BMY:US $ 2291M 160M
Clovis Oncology CLVS:US $ 9.85M 0.21M
Eli Lilly And LLY:US $ 1430.8M 522.4M
Endo International Ordinary Shares ENDP:US $ 297.12M 16.31M
Flexion Therapeutics FLXN:US $ 3.73M 1.25M
Gilead Sciences GILD:US $ 1223M 167M
GlaxoSmithKline GSK:LN 2822M 303M
Glaxosmithkline GSK:US $ 2822M 303M
Harsco HSC:US $ 434.36M 20.01M
Heron Therapeutics HRTX:US $ 11.35M 3.17M
Insmed INSM:US $ 10.18M 654K
Intrexon XON:US $ 15.45M 0.42M
Karyopharm Therapeutics KPTI:US $ 589K 549K
Lannett LCI:US $ 85M 1.65M
Ligand Pharmaceuticals LGND:US $ 11.45M 19.15M
MacroGenics MGNX:US 1.66M 1.64M
Merk MRK:US $ 3056M 14M
Pacira Pharmaceuticals PCRX:US $ 34.65M 0.6M
Pfizer PFE:US $ 9931M 2939M
Rigel Pharmaceuticals RIGL:US $ 0.15M 0.02M
Teva Pharmaceutical Industries TEVA:US $ 1989M 2M
Veracyte VCYT:US $ 21.64M 4.17M